Targeting toll-like receptor signaling as a novel approach to prevent ocular infectious diseases

Rajeev K Pandey, Fu-Shin Yu, Ashok Kumar1

  • 1Department of Ophthalmology, Kresge Eye Institute; Department of Anatomy & Cell Biology, Wayne State University School of Medicine, Detroit, MI, USA.

Insights

Toll-like receptors (TLRs) are crucial for innate immunity against pathogens. Targeting TLR signaling offers promising therapeutic strategies for preventing and treating infectious eye diseases like bacterial keratitis and endophthalmitis.

Area of Science:

  • Immunology
  • Ophthalmology
  • Microbiology

Background:

  • Toll-like receptors (TLRs) are vital components of the innate immune system, recognizing pathogen-associated molecular patterns.
  • Dysregulation of TLRs is implicated in various inflammatory and infectious conditions.
  • Recent research highlights the role of TLRs in ocular tissues, influencing the pathogenesis of eye infections.

Purpose of the Study:

  • To review the expression and function of TLRs in the eye.
  • To discuss the therapeutic potential of targeting TLR signaling for ocular infectious diseases.
  • To use bacterial keratitis and endophthalmitis as case studies.

Main Methods:

  • Literature review of studies on TLRs in ocular infections.
  • Analysis of TLR expression and signaling pathways in corneal, uveal, and retinal tissues.
  • Examination of therapeutic strategies targeting TLRs in preclinical and clinical models.

Main Results:

  • TLRs are expressed in various ocular tissues and play a significant role in the immune response to bacterial pathogens.
  • Targeting specific TLRs can modulate the inflammatory response, potentially reducing tissue damage.
  • Modulation of TLR signaling has shown promise in experimental models of bacterial keratitis and endophthalmitis.

Conclusions:

  • TLR signaling pathways are critical in the pathogenesis of infectious eye diseases.
  • Targeting TLRs represents a viable therapeutic avenue for managing ocular infections.
  • Further research is warranted to translate these findings into effective clinical treatments for infectious eye diseases.